USD 0.07
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -3.19 Million | -3.68 Million | -4.16 Million | -1.99 Million | -1.51 Million | -2.32 Million |
Net Income | -7.32 Million | -4.51 Million | -6.29 Million | -20.12 Million | -8.52 Million | -4.06 Million |
Depreciation & Amortization | 833.32 Thousand | 540.86 Thousand | 403.07 Thousand | 22.08 Thousand | 92.56 Thousand | - |
Deferred income taxes | - | -540.86 Thousand | -403.07 Thousand | -22.08 Thousand | -92.56 Thousand | - |
Stock-based compensation | 227.35 Thousand | 2.06 Million | 1.02 Million | 770.03 Thousand | 14.43 Thousand | 200.07 Thousand |
Change in working capital | 568.8 Thousand | 405.81 Thousand | 444.82 Thousand | -87.77 Thousand | 324.34 Thousand | 108.31 Thousand |
Other non-cash items | 764.03 Thousand | -1.64 Million | 402.36 Thousand | 17.23 Million | 6.67 Million | 1.35 Million |
Investing Cash Flow | -45.26 Thousand | -2.3 Million | -3.33 Million | -828.74 Thousand | -599.31 Thousand | -789.38 Thousand |
Investments in PPE | -58.16 Thousand | -395.67 Thousand | -1.08 Million | -168.92 Thousand | - | - |
Acquisitions | - | 60.16 Thousand | -1.91 Million | -683.85 Thousand | -599.31 Thousand | -789.38 Thousand |
Investment purchases | - | -1.97 Million | -391.98 Thousand | -536.78 Thousand | -462.16 Thousand | -789.38 Thousand |
Sales/Maturities of investments | - | -60.16 Thousand | -900.03 Thousand | 536.78 Thousand | - | - |
Other Investing Activities | 12.89 Thousand | 62.65 Thousand | 954.33 Thousand | 24.03 Thousand | 462.16 Thousand | 789.38 Thousand |
Financing Cash Flow | 2.92 Million | 1.29 Million | 10.17 Million | 4.82 Million | -79.22 Thousand | 1.73 Million |
Debt repayment | - | -512.41 Thousand | -3.91 Million | -9903.00 | -59.41 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -18.91 Thousand | -55.89 Thousand |
Common Stock Issuance | 2.93 Million | 757.71 Thousand | 5.23 Million | 4.82 Million | - | 1.79 Million |
Other Financing Activities | -10.81 Thousand | 1.04 Million | 8.85 Million | 3976.00 | -900.00 | -4357.00 |
Accounts receivables | -34.87 Thousand | -30.03 Thousand | -27.91 Thousand | 20.15 Thousand | 15 Thousand | 15.51 Thousand |
Accounts payables | - | 263.11 Thousand | 405.45 Thousand | -83.96 Thousand | 184.24 Thousand | - |
Inventory | - | 163.19 Thousand | -405.45 Thousand | 83.96 Thousand | -184.24 Thousand | - |
Other working capital | -4079.00 | 9545.00 | 472.73 Thousand | -107.93 Thousand | 309.33 Thousand | 92.8 Thousand |
Cash at beginning of period | 349.63 Thousand | 4.89 Million | 3.54 Million | 1.57 Million | 3.96 Million | 5.29 Million |
Cash at end of period | 36.52 Thousand | 349.63 Thousand | 6.18 Million | 3.54 Million | 1.57 Million | 3.96 Million |
Capital Expenditure | -58.16 Thousand | -395.67 Thousand | -1.08 Million | -168.92 Thousand | - | - |
Effect of forex changes on cash | 617.00 | 159.65 Thousand | -24.66 Thousand | -34.22 Thousand | -191.93 Thousand | 50.82 Thousand |
Net cash flow / Change in cash | -313.1 Thousand | -4.54 Million | 2.64 Million | 1.96 Million | -2.38 Million | -1.32 Million |
Free Cash Flow | -3.25 Million | -4.08 Million | -5.25 Million | -2.16 Million | -1.51 Million | -2.32 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.52 Million | -1.64 Million | -7.32 Million | -2.7 Million | -1.68 Million | -1.72 Million |
Depreciation & Amortization | 237.63 Thousand | 232.39 Thousand | 833.32 Thousand | 238.59 Thousand | 137.89 Thousand | 140.71 Thousand |
Deferred income taxes | - | - | - | - | -137.89 Thousand | -140.71 Thousand |
Stock-based compensation | - | - | 301.23 Thousand | 202.00 | 41.33 Thousand | 147.29 Thousand |
Change in working capital | 348.23 Thousand | -101.93 Thousand | 568.8 Thousand | 411.57 Thousand | 235.03 Thousand | -303.79 Thousand |
Other non-cash items | 367.66 Thousand | 1 Million | 764.03 Thousand | 1.59 Million | 524.94 Thousand | 660.32 Thousand |
Investing Cash Flow | -140.59 Thousand | - | -45.26 Thousand | 19.32 Thousand | -42.14 Thousand | -11.2 Thousand |
Investments in PPE | 0.95 | - | -58.16 Thousand | 24.86 Thousand | -42.14 Thousand | -24.09 Thousand |
Acquisitions | - | - | - | -13.1 Thousand | -8.57 | 13.1 Thousand |
Investment purchases | -140.59 Thousand | - | - | -5566.65 | -15.77 Thousand | -24.46 Thousand |
Sales/Maturities of investments | - | - | - | - | 0.57 | - |
Other Investing Activities | -141.62 Thousand | - | 12.89 Thousand | 13.12 Thousand | 15.77 Thousand | 24.24 Thousand |
Financing Cash Flow | 218.29 Thousand | 1.64 Million | 2.92 Million | 6157.96 | -1947.00 | 1.28 Million |
Debt repayment | -140.61 Thousand | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 77.68 Thousand | 1.64 Million | 2.93 Million | 6157.96 | -1947.00 | 1.28 Million |
Other Financing Activities | 141.64 Thousand | -6985.00 | -10.81 Thousand | - | - | 1.69 Million |
Accounts receivables | 7330.79 | 53.41 Thousand | -34.87 Thousand | -49.56 Thousand | 53.02 Thousand | -18.12 Thousand |
Accounts payables | 355.29 Thousand | -44.53 Thousand | - | 444.2 Thousand | -14.45 Thousand | 75.43 Thousand |
Inventory | - | - | - | - | 14.45 Thousand | -75.43 Thousand |
Other working capital | -14.39 Thousand | -110.82 Thousand | -4079.00 | 16.93 Thousand | 182 Thousand | -285.67 Thousand |
Cash at beginning of period | 709.09 Thousand | 36.34 Thousand | 349.63 Thousand | 536.02 Thousand | 1.46 Million | 1.43 Million |
Cash at end of period | 94.18 Thousand | 709.09 Thousand | 36.52 Thousand | 36.34 Thousand | 538.6 Thousand | 1.46 Million |
Capital Expenditure | 0.95 | - | -58.16 Thousand | 24.86 Thousand | -42.14 Thousand | -24.09 Thousand |
Effect of forex changes on cash | -710.00 | -313.00 | 617.00 | 662.00 | -621.00 | -15.28 Thousand |
Net cash flow / Change in cash | -614.9 Thousand | 672.74 Thousand | -313.1 Thousand | -499.67 Thousand | -925.7 Thousand | 29.62 Thousand |
Free Cash Flow | -683.21 Thousand | -970.89 Thousand | -3.25 Million | -512.17 Thousand | -925.08 Thousand | -1.25 Million |
600251
3629
KFINTECH
PUR
JAGSNPHARM
G1A